Why did OSR Holdings (OSRH) correct the per share price in its agreement?

The company states the amendment was filed to correct clerical errors in Exhibit 10.1, including the stated per share price. The correction is presented as an administrative fix rather than a change in the underlying business terms disclosed earlier.

OSR Holdings corrects license agreement exhibit

OSR Holdings, Inc. filed an amended current report to correct an exhibit attached to a prior disclosure.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K/A

Rhea-AI Filing Summary

OSR Holdings, Inc. filed an amended current report to correct an exhibit attached to a prior disclosure. The amendment replaces Exhibit 10.1 with a corrected version of the Global License Agreement for VXM01, dated March 23, 2026, among Vaximm AG, OSR Holdings, Inc. and BCM Europe AG. The update is described as fixing clerical errors, including the stated per share price, and does not change any other information contained in the original report.

8-K Event Classification

Item 9.01 — Financial Statements and Exhibits

1 item

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Common stock par value: $0.0001 per share Warrant exercise price: $11.50 per share Form type: 8-K/A +2 more

5 metrics

Common stock par value $0.0001 per share Par value of OSR Holdings common stock listed on Nasdaq

Warrant exercise price $11.50 per share Exercise price of redeemable warrants trading on Nasdaq

Form type 8-K/A Amended current report correcting Exhibit 10.1 only

Exhibit 10.1 date March 23, 2026 Date of Global License Agreement for VXM01

Amendment purpose Clerical corrections Replaces Exhibit 10.1 to fix errors including per share price

Key Terms

Global License Agreement, Emerging growth company, Inline XBRL, Redeemable warrants

4 terms

Global License Agreement financial

"Global License Agreement for VXM01, dated March 23, 2026"

Emerging growth company regulatory

"Emerging growth company Explanatory Note"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Inline XBRL technical

"Cover Page Interactive Data File (embedded within the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

Redeemable warrants financial

"Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share"

A redeemable warrant is a tradable right that lets its holder buy a company’s shares at a fixed price before a set date, but the issuer has the contract power to cancel (redeem) the warrant early under agreed terms. For investors this matters because early redemption can force decision-making, change the timing of when new shares might be created, and affect potential gains or dilution—much like a store coupon that the issuer can cancel by paying you off instead of letting you use it.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OSR Holdings (OSRH) change in this amended 8-K/A?

OSR Holdings updated its filing only to replace Exhibit 10.1 with a corrected Global License Agreement. The company states the changes address clerical errors, including the per share price, and do not alter any other disclosures from the original report.

Does this OSR Holdings (OSRH) amendment affect prior financial or business disclosures?

The amendment states it does not modify, amend, or update any other disclosures in the original report. Only the exhibit containing the Global License Agreement was corrected for clerical issues, including the stated per share price, leaving prior narrative unchanged.

What is Exhibit 10.1 in OSR Holdings’ (OSRH) amended filing?

Exhibit 10.1 is the Global License Agreement for VXM01 dated March 23, 2026. It is between Vaximm AG, OSR Holdings, Inc. and BCM Europe AG, and this amendment replaces that exhibit with a corrected version reflecting clerical fixes.

Does OSR Holdings (OSRH) report any new transactions in this 8-K/A?

No new transactions are introduced in the amendment. It focuses solely on replacing Exhibit 10.1 with a corrected Global License Agreement and explicitly notes that no other parts of the original report are modified or updated.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/03/2026 - 06:15 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 27, 2026

OSR HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	001-41390	84-5052822
(State or Other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

10900 NE 4th Street, Suite 2300, Bellevue, WA		98004
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code (425) 635-7700

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001 per share	OSRH	The Nasdaq Stock Market LLC
Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share	OSRHW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

This Amendment No. 1 to the Current Report on Form 8-K (the “Original Report”), filed by OSR Holdings, Inc. (the “Company”) with the Securities and Exchange Commission on April 2, 2026, is being filed solely to replace Exhibit 10.1 with a corrected version of the agreement to reflect certain clerical errors, including correction of the stated per share price.

No other changes have been made to the Original Report, and this Amendment does not modify, amend or update any other disclosures contained in the Original Report.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

EXHIBIT INDEX

Exhibit No.		Description
10.1		Global License Agreement for VXM01, dated March 23, 2026, between Vaximm AG, OSR Holdings, Inc. and BCM Europe AG (corrected version)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 3, 2026

OSR HOLDINGS, INC.

By:	/s/ Kuk Hyoun Hwang
	Name:	Kuk Hyoun Hwang
	Title:	Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents

Agreements & Contracts

EX-10.1 GLOBAL LICENSE AGREEMENT FOR VXM01, DATED MARCH 23, 2026, BETWEEN VAXIMM AG, OSR 102.5 KB